On August 4, Aptiv PLC declined 14.82% in regular trading, trading at $48.65/share, with turnover of $128 million. The sharp sell-off was triggered by the company significantly lowering its full-year outlook despite a Q2 earnings beat.

Aptiv reported Q2 adjusted EPS of $1.63, beating the analyst consensus of $1.42 by approximately 14%, while net sales of $3.27 billion missed the $3.31 billion estimate. However, the critical blow came from guidance revisions: full-year adjusted EPS was cut to $5.60-$5.80 from the prior $5.70-$6.10 range, well below the Street estimate of $5.91. Full-year revenue guidance was reduced to $12.60-$12.80 billion from $12.80-$13.20 billion, significantly trailing the $13.27 billion consensus. Q3 adjusted EPS guidance of $1.25-$1.35 also fell far short of the $1.60 market expectation.

The comprehensive downward revision across all forward-looking metrics reflected management's cautious stance on near-term business growth, severely undermining investor confidence and triggering heavy selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)